World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
26390
World Ranking
15568
National Ranking
7844

Overview

Borje S. Andersson is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple fields with a primary focus on medicine and a significant body of work in biochemistry, genetics, and molecular biology.

The scientist's main subfields of study include hematology, molecular biology, oncology, public health, environmental and occupational health, and genetics. Their research topics cover a range of areas related to blood diseases and cellular therapies.

The following are key research topics addressed in their work:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Histone Deacetylase Inhibitors Research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • CAR-T cell therapy research
  • Polyomavirus and related diseases

They have contributed to several notable publications, including the following recent papers:

  • "T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors," 2021, Journal of Hematology & Oncology
  • "Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen," 2020, Biology of Blood and Marrow Transplantation
  • "Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation," 2021, Journal of Clinical Oncology
  • "Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy," 2023, Journal of Hematology & Oncology
  • "Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial," 2021, Transplantation and Cellular Therapy

Frequent co-authors collaborating with Borje S. Andersson include:

  • Yago Nieto
  • Uday Popat
  • Elizabeth J. Shpall
  • Chitra Hosing
  • Richard E. Champlin

Their work has appeared consistently in several specialized journals, including:

  • Transplantation and Cellular Therapy
  • Blood
  • Biology of Blood and Marrow Transplantation
  • Bone Marrow Transplantation
  • Journal of Clinical Oncology

Best Publications

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

    I F Khouri;M Keating;M Körbling;D Przepiorka

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

    M Korbling;D Przepiorka;YO Huh;H Engel

  • Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

    Marcos de Lima;Daniel Couriel;Peter F. Thall;Xuemei Wang

  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

    Marcos J.G. de Lima;Ian McNiece;Simon N. Robinson;Mark Munsell

  • Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

    Marcos De Lima;Athanasios Anagnostopoulos;Mark Munsell;Munir Shahjahan

  • Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

    D. Przepiorka;N. A. Kernan;C. Ippoliti;E. B. Papadopoulos

  • Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

    N T Ueno;G Rondón;N Q Mirza;D K Geisler

  • Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

    Christopher G. Kanakry;Paul V. O'Donnell;Terry Furlong;Marcos J. De Lima

  • Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes

    J.A Russell;H.T Tran;D Quinlan;A Chaudhry

  • Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

    M. de Lima;J. McMannis;A. Gee;K. Komanduri

  • Extracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHD

    Daniel R. Couriel;Chitra Hosing;Rima M Saliba;Elizabeth Shpall

  • Tumor necrosis factor-α blockade for the treatment of acute GVHD

    Daniel Couriel;Rima Saliba;Krystal Hicks;Cindy Ippoliti

  • Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

    Donna Przepiorka;Donna Przepiorka;Terry L. Smith;Jody Folloder;Issa F Khouri

  • Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.

    Ashwin Kashyap;John Wingard;Pablo Cagnoni;Roy Jones

  • Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

    K. W. Van Besien;M. De Lima;S. A. Giralt;D. F. Moore

  • Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

    Borje S. Andersson;Peter F. Thall;Timothy Madden;Daniel Couriel

  • Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia : preliminary results

    I F Khouri;M J Keating;H M Vriesendorp;C L Reading

  • Acute and Chronic Graft-versus-Host Disease after Ablative and Nonmyeloablative Conditioning for Allogeneic Hematopoietic Transplantation

    Daniel R. Couriel;Rima M Saliba;Sergio Giralt;Issa F Khouri

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Peter F. Thall
Peter F. Thall The University of Texas MD Anderson Cancer Center
Donna Przepiorka
Donna Przepiorka US Food and Drug Administration
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Albert B. Deisseroth
Albert B. Deisseroth US Food and Drug Administration
Katayoun Rezvani
Katayoun Rezvani The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medical careers beyond a traditional M.D. route, several flexible and affordable online degrees can kick-start your journey. For registered nurses looking to advance, finding the rn to bsn cheapest programs online can save both time and money, while boosting your qualifications.

Aspiring nurses without prior experience can consider msn direct entry programs online for a direct and accelerated path into advanced nursing roles. If you’re looking for accessible entry points, there are also options for the easiest rn program to get into, making nursing school more within reach for students from diverse backgrounds.

For those interested in the administrative side of healthcare, pursuing a career in medical billing and coding is another excellent online option. Many accredited programs are available, and you can even find financial aid for medical billing and coding to help offset your education costs.

These alternative pathways can lead to rewarding healthcare careers with different educational timelines and entry requirements, making medical fields more accessible than ever before.

Best Scientists Citing Borje S. Andersson

Trending Scientists